These big medtech names performed the best in early 2017

Share

[Image from Unsplash]

Other top performers

Integer Holdings: +37%

Formerly called Greatbatch, the major medical device contract manufacturer has enjoyed steady strong growth of its stock price, which was up nearly 37% during the first 3 months of 2017.  The company has enjoyed solid performance after completing a reorganization last year that resulted from its Lake Region Medical acquisition and spin-off of Nuvectra.

Zimmer Biomet: +18%

Orthopedic device giant Zimmer Biomet managed to achieve about 18% growth in its stock price during the first 3 months of 2017. The company in January announced that it had surpassed consensus forecasts for both its 4th-quarter and full-year 2016 results, even as it saw a  –50% profit slide for the 4th quarter. “Our performance was driven, in part, by the re-acceleration of our knee and hip businesses, as well as the ongoing strength of our [sports, extremities & trauma] category and Asia-Pacific region,” president & CEO David Dvorak said at the time. Zimmer Biomet is also getting into the robotic surgery business, with plans to launch a robot-assisted surgery platform for total knee procedureslate next year.

Medtronic: +13%

The medical device giant’s stock was up more than 13% during the first 3 months of 2017. For its 3rd quarter, which ended Jan. 27, Medtronic beat the analyst consensus forecast, even as it saw a –25% profit slide. The company’s diabetes division – its smallest division – grew the most during the third quarter, up 5.7%, to $501 million. The diabetes division could grow even more: Medtronic leads the pack when it comes to developing an artificial pancreas.

How do you know your technology is disruptive enough to break conventional wisdom?

textadimage Stan Rowe knows a little something about bringing disruptive technology to market. The current Edwards Lifesciences CSO was in on the ground floor of two of medtech's most disruptive treatments, stents and transcatheter aortic valve replacement.

On December 12th, Rowe will sit down with MassDevice editor Brad Perriello for a long ranging discussion about the inside story on how these technologies came to market and what Rowe learned along the way.


Register now with the code "TAVR" and save 15% today.

Pages: 1 2 3 4 5 6 7 8

Speak Your Mind

*